Arsenic Trioxide and Sodium Phosphate, Dibasic: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Arsenic Trioxide
Sodium Phosphate, Dibasic
No brand names on recordHow we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Both arsenic trioxide and sodium phosphate have been associated with QT interval prolongation. Concomitant use of arsenic trioxide and sodium phosphate should be undertaken with caution due to the potential for additive effects on the QT interval and increased serious cardiac effects, including torsade de pointes12. If concomitant therapy is required, closely monitor ECG for QT interval prolongation.
Why it happens (mechanism)
Additive effects on QT interval
Common questions
Can I take Arsenic Trioxide and Sodium Phosphate, Dibasic together?
An increased risk of QT interval prolongation Always confirm with your pharmacist or prescriber before making any change.
How serious is the Arsenic Trioxide and Sodium Phosphate, Dibasic interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Arsenic Trioxide or Sodium Phosphate, Dibasic need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: Trisenox(R) IV injection, arsenic trioxide IV injection. Cephalon, Inc (per FDA), Frazer, PA, 2010.
- Product Information: OsmoPrep(R) oral tablets, sodium phosphate monobasic monohydrate sodium phosphate dibasic anhydrous oral tablets. Salix Pharmaceuticals, Inc, Morrisville, NC, 2009. DailyMed
Keep reading about Arsenic Trioxide
Keep reading about Sodium Phosphate, Dibasic
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist